Cryo-Cell InternationalvsJohnson & Johnson

CCEL and JNJ stock compared: price, dividend, valuation and results, from SEC filings.

CCEL

Cryo-Cell International, Inc.

$4.50

Value $36M

-7.22%
CCEL's page

Cryo-Cell International (CCEL) has a market value of $36M and Johnson & Johnson (JNJ) $689B. Over the last year, with dividends, CCEL moved +9.5% and JNJ +49.1%. Dividend yield: CCEL none, JNJ 1.85%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    CCEL$36M

    JNJ$689B

    JNJ is 19,000 times CCEL

  • Revenue, 12 months

    CCEL$31M

    JNJ$99.3B

    JNJ is 3,191 times CCEL

  • Net income, 12 months

    CCEL-$1.9M

    JNJ$16.1B

  • Operating margin

    CCEL0.6%

    JNJ–

  • ROIC

    CCEL–

    JNJ12.4%

  • P/E

    CCEL–

    JNJ42.8

  • Dividend yield

    CCEL0.0%

    JNJ1.8%

    1.9 points apart

  • 5-year return

    CCEL-55.1%

    JNJ+100.9%

    156.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

CCEL-55.1%

JNJ+100.9%

5010015020020222023202420252026
Returns by period
PeriodCCELWith dividendsJNJWith dividends
1 year since November 14, 2025+9.5%Price +9.5%+49.1%Price +45.9%
3 years since November 16, 2023+16.8%+5.3% a yearPrice +6.6%+107.3%+27.5% a yearPrice +90.4%
5 years since November 15, 2021-55.1%-14.8% a yearPrice -63.7%+100.9%+15.0% a yearPrice +74.8%
10 years since November 16, 2016+43.3%+3.7% a yearPrice +16.0%+222.3%+12.4% a yearPrice +145.6%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

CCELCryo-Cell InternationalJNJJohnson & Johnson

Valuation

CCELJNJ
Valuation
Price$4.50$285.79
Market value$36M$689B
Enterprise value (EV)–$716B
P/E–42.8
P/E, 5-year median–21.9
P/B–8.5
EV/EBIT–40.4
Free cash flow yield12.8%3.0%

Results and growth

CCELJNJ
Results and growth
Revenue, 12 months$31M$99.3B
Net income, 12 months-$1.9M$16.1B
Free cash flow, 12 months$4.7M$20.6B
Earnings per share, 12 months-$0.23$6.59
Revenue growth, year on year-1.3%6.1%
Revenue growth a year, past+0.3%over 5 years+2.7%over 5 years
EPS growth a year, past–+14.9%over 5 years

Margins and returns on capital

CCELJNJ
Margins and returns on capital
Gross margin78.5%67.6%
Operating margin0.6%–
Net margin-6.3%16.2%
ROIC–12.4%
ROE–19.7%

Balance sheet

CCELJNJ
Balance sheet
Cash$4.2M$17.2B
Total debt–$44.7B
Net debt / EBITDA–1.1
Interest cover0.1×18.0×

Dividends and buybacks

CCELJNJ
Dividends and buybacks
Dividend yield–1.8%
Dividend per share, 12 months–$5.28
Dividend growth a year, past–+5.3%over 5 years
Buyback yield0.5%0.9%
Shareholder yield0.5%2.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: CCEL or JNJ

Didn't find what you were looking for?

Ask us
Which is bigger, Cryo-Cell International or Johnson & Johnson?

By market value, Johnson & Johnson ($689B) is about 19,000.3 times Cryo-Cell International ($36M), at today's prices.

How did CCEL and JNJ stock do over the last 10 years?

Since November 16, 2016, CCEL's price moved +16.0% and JNJ's +145.6%. With dividends: CCEL +43.3% (+3.7% a year), JNJ +222.3% (+12.4% a year). Past returns do not predict future ones.

Which pays the higher dividend, CCEL or JNJ?

The dividend yield at today's price is none for Cryo-Cell International and 1.85% for Johnson & Johnson. Over the last twelve months they paid – and $5.28 per share.

Which has the higher profit margins, Cryo-Cell International or Johnson & Johnson?

Over the last twelve months, the net margin was -6.3% for Cryo-Cell International and 16.2% for Johnson & Johnson, and the operating margin 0.6% and –. Revenue was $31M and $99.3B.

Which is the better investment, Cryo-Cell International or Johnson & Johnson?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.